ZÜBLIN subsidiary to construct industrial building for medical technology in German

Wolfer & Goebel, an affiliate of STRABAG subsidiary ZÜBLIN, is building a new industrial complex in Rangendingen, about 70 km south of Stuttgart, together with joint venture partner SIEGLE+EPPLE.

The project, Erbe 4.i (Individual, instruments, intelligent, international) was commissioned by Erbe Elektromedizin GmbH. Construction on the approx. 20.000 m² site is scheduled for completion in 2023.

The proposed complex, which will replace the existing building of the medical technology company, will have three interconnected building sections for different uses: development, including a large atrium, production and logistics. All building sections will have a ground floor and two upper floors.

Advanced sustainable construction
The focus of the new building project is on sustainability in design, construction and operation from start to finish. The building complex will be one of the first industrial buildings in Germany to meet the high requirements of the KfW Efficiency House standard 40 EE.

“Everything we do is based on sustainability in all its aspects. This makes us especially proud to be able to realise a showcase sustainability project with this new building,” says Thomas Birtel, CEO of STRABAG SE.

An important sustainability component of the new building is the use of wood and wood-based materials as load-bearing elements and for the façade. The timber construction work is being carried out by ZÜBLIN Timber. As another unit of the STRABAG Group, ZÜBLIN Environmental Technology is also involved in the project.

Once the new building has commenced operations, renewable energies, including a high-performance photovoltaic system, will ensure that the high environmental targets are met.

According to the latest planning, the building is scheduled to go into operation in 2023. From then on, the building complex will be used for the manufacture of medical devices.

ZÜBLIN UNIT:
Wolfer & Goebel Bau GmbH

PROJECT SCHEDULE:
7/2021–2023

CLIENT:
Erbe Elektromedizin GmbH